Details of issuance or disposal
Disposal of treasury shares as restricted stock compensation
8,481 common shares (treasury shares)
The lower thin line represents the existing number of shares to which these shares will be added.
¥34,390,455 (total fair value)
0.01%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
| Item | Details |
|---|---|
| Type of issuance or disposal | Disposal of treasury shares as restricted stock compensation |
| Number of shares to be issued or disposed of | 8,481 common shares (treasury shares) |
| Issue price and disposal price | ¥4,055 per share (fair value; no monetary payment or contribution of assets is required) |
| Total issue value | ¥34,390,455 (total fair value) |
| Intended allottee | 7 directors (excluding directors who are Audit and Supervisory Committee members and outside directors), 8,481 shares |
| Intended allottee's holding policy | The shares may not be transferred, pledged as collateral or otherwise disposed of from the allotment date until the date on which the holder ceases to be a director of the Company. |
| Dilution Rate | 0.01% |
| Basis for determining the amount to be paid | The closing price of the Company's common shares on the Tokyo Stock Exchange on 14 July 2026 was ¥4,055. The discount rate and premium rate are Not disclosed. |
| Transfer restriction period | From 14 August 2026 (the allotment date) until the date on which the holder ceases to be a director of the Company |
| Conditions for lifting transfer restrictions | Subject to the holder continuously remaining a director of the Company throughout the service provision period (from the date of the annual general meeting of shareholders immediately preceding the allotment date to the date of the annual general meeting of shareholders held in the following year), all of the allotted shares will be released from the transfer restrictions when the transfer restriction period expires. If the holder ceases to be a director due to death or another reason deemed valid by the Board of Directors, the transfer restrictions will be released on a number of shares calculated in proportion to the number of months in office. In the event of a corporate reorganization or similar transaction, the transfer restrictions will also be released based on a prescribed calculation method. |
| Reason for acquisition without consideration | If the holder engages in certain misconduct or otherwise meets specified conditions between the start of the service provision period and the expiration of the transfer restriction period, the Company will acquire all of the allotted shares without consideration. The Company will also acquire without consideration any shares for which the transfer restrictions have not been released when the transfer restriction period expires. |
| Categories and Number of Persons Covered | 7 directors (excluding directors who are Audit and Supervisory Committee members and outside directors), 8,481 shares |
| Total Stock-Based Compensation | Up to ¥60 million per year (separate from the existing monetary compensation limit) |
| Stock Split Ratio | A 1-for-3 stock split, effective 1 April 2026 (disclosure concerning the adjustment of the annual maximum number of shares under the plan) |
Items this document does not state (14)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To provide directors with an incentive to achieve sustained growth in corporate value and promote the sharing of value with shareholders. The Company also considered the purpose of the plan, the scope of responsibilities of each eligible director and other relevant factors.